Detalhe da pesquisa
1.
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Stroke
; 52(11): 3482-3489, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34477459
2.
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Circulation
; 136(10): 907-916, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28655834
3.
Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker.
Ann Noninvasive Electrocardiol
; 21(3): 236-45, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26246430
4.
Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation.
J Electrocardiol
; 47(3): 316-23, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24508473
5.
In Silico Predictions and In Vivo Results of Drug-Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate.
Clin Pharmacol Drug Dev
; 5(5): 364-73, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27627192